Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

[A case of antisynthetase syndrome with anti-EJ antibody complicated by pericarditis].

Hayashi K, Machida Y, Katayama Y, Yokote H, Saito K, Masumura M, Miyashita A, Kobayashi M, Toru S.

Rinsho Shinkeigaku. 2019 Jan 30;59(1):21-26. doi: 10.5692/clinicalneurol.cn-001140. Epub 2018 Dec 29. Japanese.

PMID:
30606993
2.

Brain volume loss is present in Japanese multiple sclerosis patients with no evidence of disease activity.

Yokote H, Kamata T, Toru S, Sanjo N, Yokota T.

Neurol Sci. 2018 Oct;39(10):1713-1716. doi: 10.1007/s10072-018-3487-y. Epub 2018 Jul 4.

PMID:
29974307
3.

Association between Delirium and Prehospitalization Medication in Poststroke Patients.

Hosoya R, Sato Y, Ishida E, Shibamoto H, Hino S, Yokote H, Kamata T.

J Stroke Cerebrovasc Dis. 2018 Jul;27(7):1914-1920. doi: 10.1016/j.jstrokecerebrovasdis.2018.02.038. Epub 2018 Mar 27.

PMID:
29602617
4.

Case of relapsing remitting neuro-Sweet disease mimicking immunoglobulin G4-related disease.

Saito K, Nakadai T, Yokote H, Toru S.

J Dermatol. 2018 Jul;45(7):e197-e198. doi: 10.1111/1346-8138.14219. Epub 2018 Jan 20. No abstract available.

PMID:
29352502
5.

Serum retinol levels are associated with brain volume loss in patients with multiple sclerosis.

Yokote H, Kamata T, Toru S, Sanjo N, Yokota T.

Mult Scler J Exp Transl Clin. 2017 Sep 11;3(3):2055217317729688. doi: 10.1177/2055217317729688. eCollection 2017 Jul-Sep.

6.

Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases.

Yokote H, Mizusawa H.

Neural Regen Res. 2016 Mar;11(3):410-1. doi: 10.4103/1673-5374.179048. No abstract available.

7.

Retrospective survey to evaluate the safety and efficacy of Japanese botulinum antitoxin therapy in Japan.

Mottate K, Yokote H, Mori S, Horita A, Miyatsu Y, Torii Y, Kozaki S, Iwaki M, Takahashi M, Ginnaga A.

Toxicon. 2016 Feb;110:12-8. doi: 10.1016/j.toxicon.2015.11.010. Epub 2015 Nov 22.

PMID:
26615088
8.

Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice.

Nishiyama Y, Fujii T, Kanatani Y, Shinmura Y, Yokote H, Hashizume S.

Vaccine. 2015 Nov 9;33(45):6120-7. doi: 10.1016/j.vaccine.2015.09.067. Epub 2015 Oct 9.

9.

Recent advances in the study of live attenuated cell-cultured smallpox vaccine LC16m8.

Eto A, Saito T, Yokote H, Kurane I, Kanatani Y.

Vaccine. 2015 Nov 9;33(45):6106-11. doi: 10.1016/j.vaccine.2015.07.111. Epub 2015 Aug 28. Review.

PMID:
26319072
10.

Report of the international conference on regulatory endeavors towards the sound development of human cell therapy products.

Hayakawa T, Aoi T, Bravery C, Hoogendoorn K, Knezevic I, Koga J, Maeda D, Matsuyama A, McBlane J, Morio T, Petricciani J, Rao M, Ridgway A, Sato D, Sato Y, Stacey G, Sakamoto N, Trouvin JH, Umezawa A, Yamato M, Yano K, Yokote H, Yoshimatsu K, Zorzi-Morre P.

Biologicals. 2015 Sep;43(5):283-97. doi: 10.1016/j.biologicals.2015.07.009. Epub 2015 Aug 24. Erratum in: Biologicals. 2016 Jan;44(1):51.

PMID:
26315651
11.

Vaccinia virus strain LC16m8 defective in the B5R gene keeps strong protection comparable to its parental strain Lister in immunodeficient mice.

Yokote H, Shinmura Y, Kanehara T, Maruno S, Kuranaga M, Matsui H, Hashizume S.

Vaccine. 2015 Nov 9;33(45):6112-9. doi: 10.1016/j.vaccine.2015.07.076. Epub 2015 Aug 1.

12.

Trans-Activation between EphA and FGFR Regulates Self-Renewal and Differentiation of Mouse Embryonic Neural Stem/Progenitor Cells via Differential Activation of FRS2α.

Sawada T, Arai D, Jing X, Furushima K, Chen Q, Kawakami K, Yokote H, Miyajima M, Sakaguchi K.

PLoS One. 2015 May 29;10(5):e0128826. doi: 10.1371/journal.pone.0128826. eCollection 2015.

13.

Reply to "Use of the LC16m8 Smallpox Vaccine in Immunocompromised Individuals Is Still Too Risky".

Yokote H, Shinmura Y.

Clin Vaccine Immunol. 2015 May;22(5):605. doi: 10.1128/CVI.00055-15. No abstract available.

14.

Spinal cord ring enhancement in patients with neuromyelitis optica.

Yokote H, Nose Y, Ishibashi S, Tanaka K, Takahashi T, Fujihara K, Yokota T, Mizusawa H.

Acta Neurol Scand. 2015 Jul;132(1):37-41. doi: 10.1111/ane.12354. Epub 2015 Jan 7.

PMID:
25639599
15.

Taste impairment in Miller Fisher syndrome.

Yagi Y, Yokote H, Watanabe Y, Amino T, Kamata T, Kusunoki S.

Neurol Sci. 2015 May;36(5):809-10. doi: 10.1007/s10072-014-1916-0. Epub 2014 Aug 13. No abstract available.

PMID:
25116259
16.

Safety of attenuated smallpox vaccine LC16m8 in immunodeficient mice.

Yokote H, Shinmura Y, Kanehara T, Maruno S, Kuranaga M, Matsui H, Hashizume S.

Clin Vaccine Immunol. 2014 Sep;21(9):1261-6. doi: 10.1128/CVI.00199-14. Epub 2014 Jul 2.

17.

Phase III clinical trials comparing the immunogenicity and safety of the vero cell-derived Japanese encephalitis vaccine Encevac with those of mouse brain-derived vaccine by using the Beijing-1 strain.

Miyazaki C, Okada K, Ozaki T, Hirose M, Iribe K, Yokote H, Ishikawa Y, Togashi T, Ueda K.

Clin Vaccine Immunol. 2014 Feb;21(2):188-95. doi: 10.1128/CVI.00377-13. Epub 2013 Dec 11.

18.

Protective-antigen (PA) based anthrax vaccines confer protection against inhalation anthrax by precluding the establishment of a systemic infection.

Merkel TJ, Perera PY, Lee GM, Verma A, Hiroi T, Yokote H, Waldmann TA, Perera LP.

Hum Vaccin Immunother. 2013 Sep;9(9):1841-8. doi: 10.4161/hv.25337. Epub 2013 Jun 20.

19.

Serum amyloid A level is increased in neuromyelitis optica and atypical multiple sclerosis with smaller T2 lesion volume in brain MRI.

Yokote H, Yagi Y, Watanabe Y, Amino T, Kamata T, Mizusawa H.

J Neuroimmunol. 2013 Jun 15;259(1-2):92-5. doi: 10.1016/j.jneuroim.2013.03.004. Epub 2013 Apr 6.

PMID:
23566403
20.

Cervical dystonia in an Alzheimer's disease patient treated with donepezil.

Yagi Y, Watanabe Y, Yokote H, Amino T, Kamata T.

Acta Neurol Belg. 2013 Sep;113(3):363-4. doi: 10.1007/s13760-012-0143-9. Epub 2012 Oct 11. No abstract available.

PMID:
23055114
21.

Transient Charles Bonnet syndrome in a patient with reversible cerebral vasoconstriction syndrome.

Yagi Y, Watanabe Y, Yokote H, Amino T, Kamata T.

Neurol Sci. 2013 Jun;34(6):1023-5. doi: 10.1007/s10072-012-1171-1. Epub 2012 Jul 29. No abstract available.

PMID:
22843246
22.

Lacunar thalamic infarction with isolated dysesthesia in contralateral fingers.

Yagi Y, Watanabe Y, Yokote H, Amino T, Kamata T.

Acta Neurol Belg. 2013 Jun;113(2):199-200. doi: 10.1007/s13760-012-0118-x. Epub 2012 Jul 27. No abstract available.

PMID:
22837025
23.

Autoimmune polyendocrine syndrome-3 in a patient with late-onset multiple sclerosis.

Yokote H, Nagasawa M, Ichijo M, Amino T, Fujigasaki H.

Neurologist. 2012 Mar;18(2):83-4. doi: 10.1097/NRL.0b013e318248ea2a.

PMID:
22367836
24.

Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.

Kennedy JS, Gurwith M, Dekker CL, Frey SE, Edwards KM, Kenner J, Lock M, Empig C, Morikawa S, Saijo M, Yokote H, Karem K, Damon I, Perlroth M, Greenberg RN.

J Infect Dis. 2011 Nov;204(9):1395-402. doi: 10.1093/infdis/jir527. Epub 2011 Sep 15.

25.

Serological responses in humans to the smallpox vaccine LC16m8.

Johnson BF, Kanatani Y, Fujii T, Saito T, Yokote H, Smith GL.

J Gen Virol. 2011 Oct;92(Pt 10):2405-10. doi: 10.1099/vir.0.034207-0. Epub 2011 Jun 29.

26.

Smallpox vaccine safety is dependent on T cells and not B cells.

Gordon SN, Cecchinato V, Andresen V, Heraud JM, Hryniewicz A, Parks RW, Venzon D, Chung HK, Karpova T, McNally J, Silvera P, Reimann KA, Matsui H, Kanehara T, Shinmura Y, Yokote H, Franchini G.

J Infect Dis. 2011 Apr 15;203(8):1043-53. doi: 10.1093/infdis/jiq162.

27.

Ternary complex formation of EphA4, FGFR and FRS2α plays an important role in the proliferation of embryonic neural stem/progenitor cells.

Sawada T, Jing X, Zhang Y, Shimada E, Yokote H, Miyajima M, Sakaguchi K.

Genes Cells. 2010 Mar;15(3):297-311. doi: 10.1111/j.1365-2443.2010.01391.x. Epub 2010 Feb 24.

28.

Suppression of experimental autoimmune encephalomyelitis by ghrelin.

Theil MM, Miyake S, Mizuno M, Tomi C, Croxford JL, Hosoda H, Theil J, von Hörsten S, Yokote H, Chiba A, Lin Y, Oki S, Akamizu T, Kangawa K, Yamamura T.

J Immunol. 2009 Aug 15;183(4):2859-66. doi: 10.4049/jimmunol.0803362. Epub 2009 Jul 20.

29.

EGFR mutation up-regulates EGR1 expression through the ERK pathway.

Maegawa M, Arao T, Yokote H, Matsumoto K, Kudo K, Tanaka K, Kaneda H, Fujita Y, Ito F, Nishio K.

Anticancer Res. 2009 Apr;29(4):1111-7.

30.

Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8.

Saito T, Fujii T, Kanatani Y, Saijo M, Morikawa S, Yokote H, Takeuchi T, Kuwabara N.

JAMA. 2009 Mar 11;301(10):1025-33. doi: 10.1001/jama.2009.289.

PMID:
19278946
31.

Epidermal growth factor receptor lacking C-terminal autophosphorylation sites retains signal transduction and high sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor.

Maegawa M, Arao T, Yokote H, Matsumoto K, Kudo K, Tanaka K, Kaneda H, Fujita Y, Ito F, Nishio K.

Cancer Sci. 2009 Mar;100(3):552-7. doi: 10.1111/j.1349-7006.2008.01071.x. Epub 2009 Jan 14.

32.

Identification of predictive biomarkers for response to trastuzumab using plasma FUCA activity and N-glycan identified by MALDI-TOF-MS.

Matsumoto K, Shimizu C, Arao T, Andoh M, Katsumata N, Kohno T, Yonemori K, Koizumi F, Yokote H, Aogi K, Tamura K, Nishio K, Fujiwara Y.

J Proteome Res. 2009 Feb;8(2):457-62. doi: 10.1021/pr800655p.

PMID:
19140672
33.

SRPX2 is overexpressed in gastric cancer and promotes cellular migration and adhesion.

Tanaka K, Arao T, Maegawa M, Matsumoto K, Kaneda H, Kudo K, Fujita Y, Yokote H, Yanagihara K, Yamada Y, Okamoto I, Nakagawa K, Nishio K.

Int J Cancer. 2009 Mar 1;124(5):1072-80. doi: 10.1002/ijc.24065.

34.

NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora.

Yokote H, Miyake S, Croxford JL, Oki S, Mizusawa H, Yamamura T.

Am J Pathol. 2008 Dec;173(6):1714-23. doi: 10.2353/ajpath.2008.080622. Epub 2008 Oct 30.

35.

EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line.

Fukai J, Yokote H, Yamanaka R, Arao T, Nishio K, Itakura T.

Mol Cancer Ther. 2008 Sep;7(9):2768-78. doi: 10.1158/1535-7163.MCT-07-2263.

36.

N-Glycan fucosylation of epidermal growth factor receptor modulates receptor activity and sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor.

Matsumoto K, Yokote H, Arao T, Maegawa M, Tanaka K, Fujita Y, Shimizu C, Hanafusa T, Fujiwara Y, Nishio K.

Cancer Sci. 2008 Aug;99(8):1611-7. doi: 10.1111/j.1349-7006.2008.00847.x.

37.

Acute multiple brain infarction in large-artery atherosclerosis is associated with hyperhomocyst(e)inemia.

Yokote H, Shiraishi A, Shintani S, Shiigai T.

Acta Neurol Scand. 2007 Oct;116(4):243-7.

PMID:
17824903
38.

Regulation of ephexin1, a guanine nucleotide exchange factor of Rho family GTPases, by fibroblast growth factor receptor-mediated tyrosine phosphorylation.

Zhang Y, Sawada T, Jing X, Yokote H, Yan X, Sakaguchi K.

J Biol Chem. 2007 Oct 19;282(42):31103-12. Epub 2007 Aug 16.

39.

Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway.

Sakai K, Yokote H, Murakami-Murofushi K, Tamura T, Saijo N, Nishio K.

Cancer Sci. 2007 Sep;98(9):1498-503. Epub 2007 Jul 11.

40.

AZD2171 shows potent antitumor activity against gastric cancer over-expressing fibroblast growth factor receptor 2/keratinocyte growth factor receptor.

Takeda M, Arao T, Yokote H, Komatsu T, Yanagihara K, Sasaki H, Yamada Y, Tamura T, Fukuoka K, Kimura H, Saijo N, Nishio K.

Clin Cancer Res. 2007 May 15;13(10):3051-7.

41.

Pure pandysautonomia associated with interferon-alpha therapy.

Yokote H, Saitou Y, Kanda T, Mizusawa H.

J Neurol. 2007 Jul;254(7):961-2. Epub 2007 Apr 21. No abstract available.

PMID:
17450318
42.

In-frame deletion in the EGF receptor alters kinase inhibition by gefitinib.

Sakai K, Yokote H, Murakami-Murofushi K, Tamura T, Saijo N, Nishio K.

Biochem J. 2006 Aug 1;397(3):537-43.

43.

Acute disseminated myelitis associated with 5-fluorouracil and l-leucovorin treatment.

Yokote H, Shintani S, Shiigai T.

Eur Neurol. 2005;54(4):214-6. Epub 2006 Jan 6. No abstract available.

44.

Trans-activation of EphA4 and FGF receptors mediated by direct interactions between their cytoplasmic domains.

Yokote H, Fujita K, Jing X, Sawada T, Liang S, Yao L, Yan X, Zhang Y, Schlessinger J, Sakaguchi K.

Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):18866-71. Epub 2005 Dec 19.

45.
46.

Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter.

Kono K, Okano Y, Nakayama K, Hase Y, Minamikawa S, Ozawa N, Yokote H, Inoue Y.

Radiology. 2005 Aug;236(2):630-6.

PMID:
16040919
47.
48.

Three-dimensional rotation venography using the digital subtraction angiography unit with a flat-panel detector: usefulness for the transtemporal/transtentorial approaches.

Nishio A, Takami T, Ohata K, Hara M, Mitsuhashi Y, Yokote H, Inoue Y, Hosogai M, Ichida T, Ikeda S.

Neuroradiology. 2004 Nov;46(11):876-82. Epub 2004 Oct 20.

PMID:
15502998
49.

Glucocorticoid treatment of brain tumor patients: changes of apparent diffusion coefficient values measured by MR diffusion imaging.

Minamikawa S, Kono K, Nakayama K, Yokote H, Tashiro T, Nishio A, Hara M, Inoue Y.

Neuroradiology. 2004 Oct;46(10):805-11.

PMID:
15448954
50.

[Bilateral medial medullary infarction presented with monoplegia of the lower limb, followed by paraplegia and finally by tetraplegia].

Kobayashi Z, Hino T, Kanazawa T, Yokote H, Yokota T, Kanda T, Mizusawa H.

Rinsho Shinkeigaku. 2003 Apr;43(4):195-8. Japanese.

PMID:
12884832

Supplemental Content

Loading ...
Support Center